Culture

Virtual therapy: The 'new normal' after COVID-19

image: The expansion of telepsychiatry may outlast the COVID-19 pandemic that caused it. When the stay-at-home order took effect in West Virginia, James Berry--a clinician with the WVU School of Medicine--was part of the team that moved the Chestnut Ridge Center's therapy sessions online. Just 10% to 15% of patients had connectivity problems. That's fewer than clinicians expected. And--anecdotally--clinicians found that many patients were more forthcoming during virtual sessions than in-person ones.

Image: 
Aira Burkhart/WVU

Once the COVID-19 pandemic is over, a lot of things will go back to normal. We'll stop wearing masks. We'll crowd into restaurants. We'll walk whatever direction we want to down grocery store aisles. But some changes that the pandemic spurred might be here to stay. Among them: the expansion of telepsychiatry.

"This will be part of the new normal," said James Berry, a clinician with the West Virginia University School of Medicine. "The genie is now out of the bottle, and it isn't going back in."

After West Virginia's stay-at-home order took effect in March, Berry was part of the team that transitioned outpatient behavioral-health visits to telepsychiatry at WVU's Chestnut Ridge Center. These visits included group therapy sessions for people with opioid use disorder.

"Behavioral health issues are very treatable and manageable problems," said Berry, who chairs the Department of Behavioral Medicine and Psychiatry and directs addiction services at CRC. "Whatever we can do to create access for people who need help is something that we need to prioritize. People don't have to suffer."

In a new letter published in the Journal of Addiction Medicine, Berry and his colleagues explain how large-scale deployment of telepsychiatry is possible for both individual- and group-based visits.

His team of School of Medicine researchers and WVU Medicine clinicians includes Erin Winstanley, Laura Lander, Wanhong Zheng, Kari-Beth Law and Ashley Six-Workman.

Before the stay-at-home order, virtual care and therapy was offered for rural clinics only; however, during the week that the stay-at-home order began, CRC moved 75% of its on-site therapy sessions to Zoom. Soon after, 98% of the sessions had gone virtual.

Prior to the pandemic, the department was conducting pioneering telepsychiatry services to rural areas across West Virginia through funding from the Health Resources and Services Administration, as overseen by Law. With this experience, Law was able to lead the transition at CRC to virtual care.

Bad internet connections don't preclude good emotional connections

Even though West Virginia has the fourth-lowest rate of household broadband access in the nation, only 10% to 15% of the patients in CRC's virtual therapy sessions had connectivity problems--a percentage that was lower than Berry expected.

"Over time, people became very creative in making the connectivity work," he said. "For instance, several patients didn't have broadband access in their home, but many had access to a smartphone. It's just that not everybody had service. People used public Wi-Fi options in restaurant parking lots to conduct their visits. While this does not mean that access to quality broadband services is not a priority, it does speak to people's resilience and need for access.

Looking at a screen--instead of directly into someone's face in the same room--didn't make patients more reticent to participate in therapy sessions. If anything, the opposite was true.

"I don't know if it's because they were in the comfort of their own home or because they didn't feel like all eyes were on them, but one of the things I noticed early on is that people seemed more comfortable sharing details than they would have been in person," Berry said.

The best laid plans

Even before the pandemic, CRC had been planning to expand its telepsychiatry options. They just didn't expect to do it so quickly.

"Our five- to 10-year plan was to allow access for much of our care into the virtual world, but there were many barriers," Berry said.

One of those barriers was patients' and clinicians' unfamiliarity with telepsychiatry. Another was some insurers' unwillingness to pay for virtual therapy--or therapy in a patient's home--even when they would cover comparable in-person therapy.

Regulations and legislation have hindered the adoption of telepsychiatry, too. "As a physician, for instance, you're licensed to practice in a particular state," Berry said. "I'm licensed to practice medicine in West Virginia. Pre-pandemic, that meant that in order to treat somebody who was in a state that doesn't participate in the Interstate Medical Licensure Compact--for example, Ohio--I would have to have an Ohio license, or there would have to be an arrangement made between our two states that would allow me to do that. You can imagine the difficulty that would have presented when it comes to treating patients across state lines."

But the pandemic swept many of those obstacles away. "Now we're seeing patients from all over the country," Berry said.

Coming together while staying apart

Wherever they live, many of the patients that Berry and his colleagues are seeing may need more emotional support than usual right now. The feelings of isolation that can accompany staying at home--and seeing friends and family less frequently--can trigger new mental health problems and worsen old ones.

Social distancing has been linked to declines in mental health outcomes, increases in substance use and upticks in crises such as suicidal ideation.

For these reasons, telepsychiatry can be crucial during the pandemic.

Berry said, "When we saw the pandemic coming in early March, I said, 'Listen, everybody. We are already facing a behavioral health epidemic, an overdose epidemic and a suicide epidemic. Now we've got this COVID viral epidemic. Once people are isolated and don't have their personal connections anymore, we are going to be facing a huge increase in the number of people who are experiencing severe psychological distress and disorders. We need to be prepared for this.'"

If Berry could go back to the early days of those preparations--knowing what he knows now--he would give himself one piece of advice: be patient.

"Early on, it was really easy to get frustrated when you're talking to somebody and their connection is going in and out," he said. "But it's just a growing pain. Take a step back. If somebody connects at all, that's a victory."

Credit: 
West Virginia University

"The machine as extension of the body"

image: Prof. Gordon Cheng whats to dig deeper into understanding how the brain functions

Image: 
Astrid Eckert / TUM

Combining neuroscience and robotic research has gained impressive results in the rehabilitation of paraplegic patients. A research team led by Prof. Gordon Cheng from the Technical University of Munich (TUM) was able to show that exoskeleton training not only helped patients to walk, but also stimulated their healing process. With these findings in mind, Prof. Cheng wants to take the fusion of robotics and neuroscience to the next level.

Prof. Cheng, by training a paraplegic patient with the exoskeleton within your sensational study under the "Walk Again" project (LINK!), you found that patients regained a certain degree of control over the movement of their legs. Back then, this came as a complete surprise to you ...

... and it somehow still is. Even though we had this breakthrough four years ago, this was only the beginning. To my regret, none of these patients is walking around freely and unaided yet. We have only touched the tip of the iceberg. To develop better medical devices, we need to dig deeper in understanding how the brain works and how to translate this into robotics.

In your paper published in Science Robotics this month, you and your colleague Prof. Nicolelis, a leading expert in neuroscience and in particular in the area of the human-machine interface, argue that some key challenges in the fusion of neuroscience and robotics need to be overcome in order to take the next steps. One of them is to "close the loop between the brain and the machine" - what do you mean by that?

The idea behind this is that the coupling between the brain and the machine should work in a way where the brain thinks of the machine as an extension of the body. Let's take driving as an example. While driving a car, you don't think about your moves, do you? But we still don't know how this really works. My theory is that the brain somehow adapts to the car as if it is a part of the body. With this general idea in mind, it would be great to have an exoskeleton that would be embraced by the brain in the same way.

How could this be achieved in practice?

The exoskeleton that we were using for our research so far is actually just a big chunk of metal and thus rather cumbersome for the wearer. I want to develop a "soft" exoskeleton - something that you can just wear like a piece of clothing that can both sense the user's movement intentions and provide instantaneous feedback. Integrating this with recent advances in brain-machine interfaces that allow real-time measurement of brain responses enables the seamless adaptation of such exoskeletons to the needs of individual users. Given the recent technological advances and better understanding of how to decode the user's momentary brain activity, the time is ripe for their integration into more human-centered or, better ? brain-centered ? solutions.

What other pieces are still missing? You talked about providing a "more realistic functional model" for both disciplines.

We have to facilitate the transfer through new developments, for example robots that are closer to human behaviour and the construction of the human body and thus lower the threshold for the use of robots in neuroscience. This is why we need more realistic functional models, which means that robots should be able to mimic human characteristics. Let's take the example of a humanoid robot actuated with artificial muscles. This natural construction mimicking muscles instead of the traditional motorized actuation would provide neuroscientists with a more realistic model for their studies. We think of this as a win-win situation to facilitate better cooperation between neuroscience and robotics in the future.

You are not alone in the mission of overcoming these challenges. In your Elite Graduate Program in Neuroengineering, the first and only one of its kind in Germany combining experimental and theoretical neuroscience with in-depth training in engineering, you are bringing together the best students in the field.

As described above, combining the two disciplines of robotics and neuroscience is a tough exercise, and therefore one of the main reasons why I created this master's program in Munich. To me, it is important to teach the students to think more broadly and across disciplines, to find previously unimagined solutions. This is why lecturers from various fields, for example hospitals or the sports department, are teaching our students. We need to create a new community and a new culture in the field of engineering. From my standpoint, education is the key factor.

Credit: 
Technical University of Munich (TUM)

Strong social support decreases mental health problems in young adults

A team of McGill University researchers has found that young adults who perceived higher levels of social support reported fewer mental health problems.

In a study published today in JAMA Network Open, the team led by Marie-Claude Geoffroy, Assistant Professor in the Department of Educational and Counseling Psychology at McGill, reassessed the impact of the presence and awareness of social support, such as family and friends, as a safeguard against mental health problems, including depression, anxiety, suicidal ideation and suicide attempts. Their results indicate that young adults who perceived higher levels of social support - the feeling that there is someone who they can depend on for help should they need it - at the age of 19, showed lower levels of depression and anxiety symptoms one year later.

"Our study shows that even in cases where people previously experienced mental health problems, social support was beneficial for mental health later on," says Prof. Geoffroy, who holds the Canada Research Chair in Youth Suicide Prevention. "We discovered potential benefits of promoting and leveraging social support as a means to protect the mental health of young adults, even in individuals who experienced mental health problems at an earlier developmental stage in life. That social support is not only beneficial for depression, but for other salient mental health outcomes as well."

The power of perception

The team used data from the Quebec Longitudinal Study on Child Development, collected by the Institut de la statistique du Québec from over 1,000 participants of a representative birth cohort of individuals born in the province of Quebec. Following participants since their birth in 1997 and 1998, the researchers looked at their levels of perceived social support at the onset of adulthood.

The researchers found that people who experienced greater levels of social support experienced 47% less severe depression and 22% less anxiety than those with less social support. The team also found that those who reported higher levels of perceived social support were at a 40% decreased risk of experiencing suicidal ideation and attempts.

"Our study was conducted before the current COVID-19 pandemic, so we do not know whether our results will apply in the current context," adds Sara Scardera, a master's student in McGill's School/Applied Child Psychology program under the supervision of Prof. Geoffroy and co-author of the study. "However, in a 'normal' context, youth who perceived that they had someone to rely on reported better mental health outcomes. We believe that is beneficial to offer help to those in need, and to make sure your friends know that they can count on you."

The data collection is ongoing, therefore new mental health data will be available when participants turn 23 years old over the course of the 2021 winter season. The researchers will verify whether the same patterns of association have been present during the COVID-19 pandemic.

Future lines of research will examine whether certain types of social support - for example, parents vs. friends - is more beneficial to the mental health of young adults.

Credit: 
McGill University

Development of the first biohybrid artificial retina built with silk fibroin and retinal cells.

"The biohybrid retina is a cell therapy for the reconstruction of the damaged retina by implanting healthy cells in the patient's eye," says Fivos Panetsos, director of the Neuro-computation and Neuro-robotics Group of the UCM and member of the Institute of Health Research of the Hospital Clínico San Carlos de Madrid (IdISSC).

The cells of the artificial retina adhere to very thin silk fibroin biofilms - a biomaterial 100% biocompatible with human tissue - and covered by a gel which protects them during eye surgery and allows them to survive during the time they need to get integrated with thesurrounding tissue after transplantation.

"The transplanted retina also contains mesenchymal cells that function as producers of neuroprotective and neuroreparative molecules and facilitate functional integration between implanted and patient cells", adds UCM's researcher and director of the study, published in the Journal of Neural Engineering .

One more step in a problem with more than 196 million affected

To build this artificial retina, researchers have developed silk fibroin films with mechanical characteristics similar to Bruch's membrane - the layer of cells that supports the neural retina. Then, they have biofunctionalized them so that retinal cells could adhere, and on them they have grown epithelial and neural cells. Finally, they have carried out an in vitro study of the structural and functional characteristics of the biohybrid.

Age-Related Macular Degeneration (AMD) is a neurodegenerative disease that causes a progressive loss of central vision and even blindness in its most advanced stage. Triggered by heterogeneous, complex and still poorly understood mechanisms, it is the leading cause of irreversible vision loss in people over 65 years of age and affects more than 196 million people worldwide.

AMD is an incurable disease, and current treatments can only alleviate symptoms and slow down the progression of the disease. "This research is an important step towards solving the problem of blindness faced by AMD patients", concludes Panetsos.

Credit: 
Universidad Complutense de Madrid

Virtual therapy: The 'new normal' after COVID-19

image: The expansion of telepsychiatry may outlast the COVID-19 pandemic that caused it. When the stay-at-home order took effect in West Virginia, James Berry--a clinician with the WVU School of Medicine--was part of the team that moved the Chestnut Ridge Center's therapy sessions online. Just 10% to 15% of patients had connectivity problems. That's fewer than clinicians expected. And--anecdotally--clinicians found that many patients were more forthcoming during virtual sessions than in-person ones.

Image: 
WVU/Aira Burkhartt

Once the COVID-19 pandemic is over, a lot of things will go back to normal. We’ll stop wearing masks. We’ll crowd into restaurants. We’ll walk whatever direction we want to down grocery store aisles. But some changes that the pandemic spurred might be here to stay. Among them: the expansion of telepsychiatry.

“This will be part of the new normal,” said James Berry, a clinician with the West Virginia University School of Medicine. “The genie is now out of the bottle, and it isn’t going back in.”

After West Virginia’s stay-at-home order took effect in March, Berry was part of the team that transitioned outpatient behavioral-health visits to telepsychiatry at WVU’s Chestnut Ridge Center. These visits included group therapy sessions for people with opioid use disorder.

“Behavioral health issues are very treatable and manageable problems,” said Berry, who chairs the Department of Behavioral Medicine and Psychiatry and directs addiction services at CRC. “Whatever we can do to create access for people who need help is something that we need to prioritize. People don’t have to suffer.”

In a new letter published in the Journal of Addiction Medicine, Berry and his colleagues explain how large-scale deployment of telepsychiatry is possible for both individual- and group-based visits.

His team of School of Medicine researchers and WVU Medicine clinicians includes Erin Winstanley, Laura Lander, Wanhong Zheng, Kari-Beth Law and Ashley Six-Workman.

Before the stay-at-home order, virtual care and therapy was offered for rural clinics only; however, during the week that the stay-at-home order began, CRC moved 75% of its on-site therapy sessions to Zoom. Soon after, 98% of the sessions had gone virtual.

Prior to the pandemic, the department was conducting pioneering telepsychiatry services to rural areas across West Virginia through funding from the Health Resources and Services Administration, as overseen by Law. With this experience, Law was able to lead the transition at CRC to virtual care.

Bad internet connections don’t preclude good emotional connections

Even though West Virginia has the fourth-lowest rate of household broadband access in the nation, only 10% to 15% of the patients in CRC’s virtual therapy sessions had connectivity problems—a percentage that was lower than Berry expected.

“Over time, people became very creative in making the connectivity work,” he said. “For instance, several patients didn’t have broadband access in their home, but many had access to a smartphone. It’s just that not everybody had service. People used public Wi-Fi options in restaurant parking lots to conduct their visits. While this does not mean that access to quality broadband services is not a priority, it does speak to people’s resilience and need for access.

Looking at a screen—instead of directly into someone’s face in the same room—didn’t make patients more reticent to participate in therapy sessions. If anything, the opposite was true.

“I don’t know if it’s because they were in the comfort of their own home or because they didn’t feel like all eyes were on them, but one of the things I noticed early on is that people seemed more comfortable sharing details than they would have been in person,” Berry said.

The best laid plans

Even before the pandemic, CRC had been planning to expand its telepsychiatry options. They just didn’t expect to do it so quickly.

“Our five- to 10-year plan was to allow access for much of our care into the virtual world, but there were many barriers,” Berry said.

One of those barriers was patients’ and clinicians’ unfamiliarity with telepsychiatry. Another was some insurers’ unwillingness to pay for virtual therapy—or therapy in a patient’s home—even when they would cover comparable in-person therapy.

Regulations and legislation have hindered the adoption of telepsychiatry, too. “As a physician, for instance, you’re licensed to practice in a particular state,” Berry said. “I’m licensed to practice medicine in West Virginia. Pre-pandemic, that meant that in order to treat somebody who was in a state that doesn’t participate in the Interstate Medical Licensure Compact—for example, Ohio—I would have to have an Ohio license, or there would have to be an arrangement made between our two states that would allow me to do that. You can imagine the difficulty that would have presented when it comes to treating patients across state lines.”

But the pandemic swept many of those obstacles away. “Now we’re seeing patients from all over the country,” Berry said.

Coming together while staying apart

Wherever they live, many of the patients that Berry and his colleagues are seeing may need more emotional support than usual right now. The feelings of isolation that can accompany staying at home—and seeing friends and family less frequently—can trigger new mental health problems and worsen old ones.

Social distancing has been linked to declines in mental health outcomes, increases in substance use and upticks in crises such as suicidal ideation.

For these reasons, telepsychiatry can be crucial during the pandemic.

Berry said, “When we saw the pandemic coming in early March, I said, ‘Listen, everybody. We are already facing a behavioral health epidemic, an overdose epidemic and a suicide epidemic. Now we’ve got this COVID viral epidemic. Once people are isolated and don’t have their personal connections anymore, we are going to be facing a huge increase in the number of people who are experiencing severe psychological distress and disorders. We need to be prepared for this.’”

If Berry could go back to the early days of those preparations—knowing what he knows now—he would give himself one piece of advice: be patient.

“Early on, it was really easy to get frustrated when you’re talking to somebody and their connection is going in and out,” he said. “But it’s just a growing pain. Take a step back. If somebody connects at all, that’s a victory.”

Credit: 
West Virginia University

Male weeds may hold key to their own demise

image: University of Illinois scientists are getting closer to finding the genes for maleness in waterhemp and Palmer amaranth, two of the most troublesome agricultural weeds in the U.S. Finding the genes could enable new 'genetic control' methods for the weeds, which, in many places, no longer respond to herbicides.

Image: 
Lauren D. Quinn, University of Illinois

URBANA, Ill. - Scientists are getting closer to finding the genes for maleness in waterhemp and Palmer amaranth, two of the most troublesome agricultural weeds in the U.S.

Finding the genes could enable new "genetic control" methods for the weeds, which, in many places, no longer respond to herbicides.

"If we knew which genes control maleness and we could make those genes proliferate within the population, every plant in the field would be a male after a few generations, and theoretically, the population would crash," says Pat Tranel, professor and associate head in the Department of Crop Sciences at the University of Illinois and lead author on a study in New Phytologist.

Tranel and his colleagues had previously identified molecular markers associated with the male genomic region. After sequencing male genomes for both species, the researchers were able to use those markers to zero in on the male-specific region. Now, they are within 120 to 150 genes of finding their target.

"We're confident most of those 120 or so genes are probably doing nothing. It's just stuff that's accumulated in that region of the genome," Tranel says. "If I had to guess, I'd say maybe 10 of them are actually doing something relevant."

Narrowing down the genes related to gender in these weeds could have practical value for control, but the study also sheds light on the phenomenon of dioecy - male and female sexual organs on separate individuals - more generally. The vast majority of animals are dioecious, but it's rare in plants. More than 90% of flowering plants have both sexual organs on the same individual, and often within the same flower.

Waterhemp and Palmer amaranth, however, are dioecious.

Dioecy means it's impossible for a plant to self-pollinate; instead, female gametes must be fertilized by male pollen from another plant. That's a good thing for ensuring genetic diversity in a population. And it's likely what has made waterhemp and Palmer amaranth so successful at evading the detrimental effects of multiple herbicides.

"To date, waterhemp and Palmer amaranth have evolved resistance to herbicides spanning seven and eight modes of action, respectively. Dioecious reproduction results in all these resistance traits being mixed and matched within individuals. This mixing has allowed populations of both species to combine multiple herbicide resistances, leaving producers with few effective herbicide choices," Tranel says.

Understanding the rare phenomenon of dioecy in plants can help scientists piece together how traits are inherited from each parent, and to understand how the phenomenon evolves.

Unlike in animals, in which dioecy is thought to have evolved just once, scientists believe dioecy in plants has evolved numerous times. And, according to Tranel's study, it appears to have evolved independently in waterhemp and Palmer amaranth, two very closely related species.

"I'm not ready to say we absolutely know they evolved separately, but all the information we found supports that idea. Only two of the 120-150 genes were similar to each other across the two species," Tranel says.

One of those shared genes, Florigen, helps plants respond to day length by initiating flowering. Tranel doesn't know yet whether it determines the gender of flowers, but he's intrigued that it showed up in the male-specific Y region for both species.

"We don't know for sure, but maybe it's involved with males flowering earlier than females. That could be advantageous to males because then they'd be shedding pollen when the first females become receptive. So if, in fact, Palmer and waterhemp really did evolve dioecy separately, but both acquired this Florigen gene for a fitness advantage, that would be a cool example of parallel evolution."

Tranel hopes to narrow down the male-specific Y region in both species even further to isolate the genes that determine maleness. There's no guarantee a genetic control solution will be developed once those genes are identified - Tranel would likely need to attract industry partners for that - but having such a tool is not as far off as it once was.

Credit: 
University of Illinois College of Agricultural, Consumer and Environmental Sciences

Carolina Sandhills Salamander: New species added to species-rich North Carolina

image: Carolina Sandhills salamander (Eurycea arenicola) in life from North Carolina.

Image: 
Todd Pusser

Already possessing more salamander species than any other state in the country with 63, North Carolina has just added one more to make it 64. The aptly named Carolina Sandhills Salamander (Eurycea arenicola) is found in association with springs, seepages and small blackwater streams of the Sandhills region of North Carolina.

The Carolina Sandhills Salamander was previously lumped in as an unusual population of the Southern Two-lined Salamander (Eurycea cirrigera), but researchers at the North Carolina Museum of Natural Sciences applied next generation sequencing technology to show that the new species differs genetically (in both the mitochondrial and nuclear genome) from other species of two-lined salamanders (Eurycea bislineata complex). These results, published in Herpetologica today, back up more conspicuous evidence, as the Carolina Sandhills Salamander also differs in coloration, size and natural history from other members of the complex.

It's a discovery 50 years in the making. The first specimen was collected and identified in October 1969 and brought to the attention of the NC Museum's Alvin Braswell, then the assistant curator for lower invertebrates and now only recently retired. At first, Braswell thought that this original specimen was just a weird individual of Eurycea cirrigera, but then in the mid-1970s he started finding more "weird individuals" and thought, "Whoa, maybe there's something to this." As it turned out, the original specimen had been misidentified. Among other things, Eurycea arenicola is smaller on average in size, and mature individuals have a pronounced reddish color. "It's a real neat critter," notes co-author Braswell.

The fact that its range is restricted to the Sandhills is also unique. The Sandhills, according to Braswell, is an area that comprises the "best of what's left in North Carolina" of the once extensive Longleaf Pine ecosystem, which stretched from southeast Virginia all the way south to Florida. So much of that ecosystem, roughly 95 percent, has been altered or lost through development and conversion to other land use practices, but the NC Sandhills includes extensive Game Lands and Fort Bragg, protecting some very important habitat. The name itself reflects the species' tie to the Sandhills, as arenicola means "dweller of a sandy place" in Latin.

In the 1980s, Braswell began the process of describing the new species but never completed it. Braswell, burdened with administrative duties, ultimately turned it over to Bryan Stuart, who joined the NC Museum as research curator of herpetology in 2008, imploring him to "take it and run with it." Finally, in 2013 Stuart received a National Science Foundation Research Opportunity Award (ROA) that enabled detailed genetic research using a new, next generation sequencer. "With that machine, we were able to sequence a sufficiently large number of genes to test the distinct species status of the Carolina Sandhills Salamander," says Stuart, lead author on the paper.

Carolina Sandhills Salamander specimens were located and collected in Harnett, Hoke, Montgomery, Moore, Richmond, Robeson and Scotland counties. "Almost every known specimen of the new species is housed in our collection, with just a handful of individuals at a few other museums," notes Jeff Beane, collections manager for herpetology at the NC Museum and a co-author on the paper. "No records are yet known from South Carolina, but we have a record in North Carolina that is only two miles from the state line, so it gets close."

Despite being unnamed until this paper came out, the small geographic range of the Carolina Sandhills Salamander has prompted it to be listed on the W3 Watch List by the North Carolina Natural Heritage Program - meaning it is a "species that is poorly known and perhaps needs listing in upcoming years."

"This research also shows that there are other undescribed species in this complex that await description, even some that occur in North Carolina," Stuart adds. "So, there is definitely more to do with two-lined salamanders in the state."

Credit: 
North Carolina Museum of Natural Sciences

Negative reviews boost sales

image: Aleksei Smirnov, Assistant Professor, Faculty of Economic Sciences (HSE University)

Image: 
Aleksei Smirnov (HSE University)

Aleksei Smirnov, Assistant Professor, HSE University Faculty of Economic Sciences, and Egor Starkov, Assistant Professor, University of Copenhagen, have constructed a mathematical model that explains why it is advantageous for sellers not to delete negative reviews of their products. A study detailing this conclusion has been accepted for publication in The American Economic Journal: Microeconomics.

Empirical studies have indicated that consumers are more likely to buy a product with a rating slightly below a perfect one rather than a perfect one. Using game theory, the researchers analysed how negative reviews affect sales.

The researchers' model, which they presented in their paper 'Bad News Turned Good: Reversal under Censorship', involves two sets of participants: sellers, who know the true quality of the products they are selling and can selectively publish reviews about it, and buyers, who do not know a product's quality and can be categorized as either 'naïve' or 'rational'. Rational buyers use all available information to determine the quality of a product, while naïve buyers tend to take product reviews at face value and do not make any further inference.

'If there were only naïve consumers in the market, sellers would leave only perfect reviews, because the naïve consumers believe what they read and there is no reason to disenchant them with negative reviews,' Aleksei Smirnov explains.

However, in reality there are both naïve and rational consumers in the market, and the situation is as follows. Good reviews are perceived positively by everyone. Bad reviews are bad for the naïve consumers, but for the rational consumers these reviews actually increase their confidence in the quality of a product. Why? Because, the authors say, every bad review weakens sales among naïve consumers. Therefore, only a seller of a high quality product will be confident enough to publish it--they can be certain that in the future their product will garner positive feedback, and sales among rational consumers will compensate for any losses among naïve consumers.

Thus, bad reviews become a positive signal to rational consumers, and, by attracting more rational consumers, sellers boost sales.

Examples where a seller is not only not shy about negative feedback but, on the contrary, flaunts it, can be found literally on the street. For example, roadside advertising billboards for digitec, the largest electronics retailer in Switzerland, feature poor customer reviews of their products. The authors of the study do not have data on how this advertising campaign has affected digitec's profits, but given that the billboards have been around for years, it can be assumed that this marketing move has been quite successful.

Credit: 
National Research University Higher School of Economics

Gene could help predict response to cervical cancer treatment

UCLA RESEARCH BRIEF

FINDINGS

UCLA researchers have identified a potential diagnostic marker that could help predict how likely someone with cervical cancer is to respond to the standard treatment of chemotherapy and radiation.

The scientists found that PACS-1, a gene that resides on a small segment of the long arm of chromosome 11, is overexpressed in cancer tissues, which can result in cancer growth and spread. Further, they discovered that translocation of the PACS-1 protein from outside to inside the cell nucleus -- a function required for normal cell growth -- plays a role in the development of cervical cancer that is resistant to chemotherapy and radiation. Higher levels of PACS-1 expression in the nucleus could indicate resistance to the treatment, the researchers say.

BACKGROUND

Cervical cancer is the second leading cause of cancer-related death among women worldwide. While infection with human papillomaviruses plays a significant role in cervical cancer development, the presence of a virus alone is not enough to cause cancer; genetics and environmental factors such as smoking and poor eating habits also play a role. Therefore, it is important to identify biological markers as targeting agents for diagnosis and treatment.

METHOD

The researchers performed a western blot, a technique for detecting specific protein molecules from among a mixture of proteins, on cervical tumors and healthy cervical tissue and discovered an overexpression of PACS-1 in the tumor tissues. The team then developed in vitro human cell line models to assess the protein's role in cell growth. Finally, they used a fluorescence-activated sorter analysis to help determine if the overexpression of PACS-1 protein was associated with cancer chemo resistance.

IMPACT

If confirmed in animal studies, the use of PACS-1 as a diagnostic marker could help lead to the development of therapeutic strategies to overcome treatment resistance in cervical cancer. Alternative methods of treatment, including the inhibition of PACS-1 expression, could be used in combination with chemotherapy or immune system-activating agents.

AUTHORS

The study's senior author is Eri Srivatsan, a professor of surgery at the David Geffen School of Medicine at UCLA and member of UCLA's Jonsson Comprehensive Cancer Center and Molecular Biology Institute. The first author is Mysore Veena, a scientist at the Geffen School of Medicine.

JOURNAL

The study is published online in the Journal of Biological Chemistry.

FUNDING

The research was supported in part by the National Cancer Institute and the Veterans Affairs Greater Los Angeles Healthcare System.

Credit: 
University of California - Los Angeles Health Sciences

Financial distress negatively impacts well-being, satisfaction of breast cancer patients

video: Research News: Financial distress negatively impacts well-being of breast cancer patients

Image: 
American College of Surgeons

CHICAGO (December 11, 2020): Financial toxicity among breast cancer patients is independently associated with worse psychological well-being following a mastectomy or lumpectomy operation. However, even small improvements in financial pressure associated with treatment-related costs can lead to better mental well-being and higher patient satisfaction with breast reconstruction, according to an "article in press" published on the website of the Journal of the American College of Surgeons ahead of print.

Women undergoing breast cancer surgery are vulnerable to financial stress due to the expensive and extended duration of treatment. High out-of-pocket costs can take a major toll on a patient's health, leading to financial toxicity (the harm or stress a person experiences due to the unaffordability of his or her medical care).

"Breast cancer therapy is highly sensitive to patient preferences, so right from the start patients are expected to make a lot of decisions and each one has trade-offs," said lead study author Christopher J. Coroneos, MD, MSc, an assistant professor of plastic surgery at McMaster University in Ontario, Canada. "There is a unique set of decisions that a patient has to make--undergoing a lumpectomy versus mastectomy, undergoing chemotherapy, adjuvant therapy and radiation, and then breast reconstruction--that is why breast cancer is different from other cancers."

Even so, timely and in-depth discussions between providers and patients about the cost of cancer care are uncommon. This is the first study to examine the connection between financial distress and quality-of-life outcomes (overall and condition specific) in women who undergo surgery for breast cancer, according to the authors.

Researchers analyzed the results of three self-reported surveys and medical record data for 532 women who underwent lumpectomy or mastectomy at The University of Texas MD Anderson Cancer Center in Houston. Patients were aged 18 years and older and had completed the surveys within 18 months of their breast cancer operation. Most of the patients (64 percent) underwent breast reconstruction. The median annual household income was reported between $80,000 and $120,000, well above the national average.

Using the COST (COmprehensive Score for financial Toxicity) questionnaire, researchers identified patients in financial distress. In addition, participants responded to questions from the BREAST-Q and SF-12 surveys, designed to assess quality of life, mental well-being, and physical satisfaction after undergoing breast reconstruction; a lower score represents a worse outcome.

After adjusting for multiple confounding factors, the analysis showed that financial toxicity, as reflected in a lower COST score, was strongly associated with lower BREAST-Q and SF-12 scores, indicating worse outcomes. Further, COST had the largest impact on one particular outcome, psychological well-being, with a one unit increase in COST correlated with a 0.89 unit increase in the psychological well-being score.

"Even a small change in financial toxicity translates to an important change in psychosocial well-being," Dr. Coroneos said. The data also showed a positive relationship between patients' psychological well-being and their own perceived satisfaction with the outcome of their breast reconstruction.

The study builds on previous findings examining the link between financial toxicity and quality of life. However, this study is important because it uses validated patient reported outcome measures for the analysis.

"In this world of patient-centered outcomes and value-based care, there are two takeaway points from our study. First, for populations at high risk for financial toxicity, deliberations around treatment costs are incredibly important. Second, early intervention in instances of self-reported financial toxicity will be a key element of maximizing patient-reported outcomes in breast cancer surgery. This is because financial toxicity really does dampen the high-quality, patient-centered outcomes we are capable of delivering," said study senior author Anaeze C. Offodile II, MD, MPH, an assistant professor of plastic surgery at The University of Texas MD Anderson Cancer Center, Houston.

Currently, the authors are conducting a prospective multi-center trial, reproducing this work in a variety of settings. They hope to get a more in-depth understanding of how economic well-being impacts quality of life outcomes in breast cancer surgery (timing, triggers and duration), and ultimately, how interventions that improve the economic well-being of cancer patients could lead to improvements in care.

"What clinicians have to do with these study results is to consider the financial reserve patients have when discussing breast cancer management." Dr. Coroneos said. "From a research perspective, integrating the financial risk and patient reported outcomes can inform decision-making models, and is especially important in vulnerable populations."

Credit: 
American College of Surgeons

Using water fleas, UTA researchers investigate adaptive evolution

image: Water daphnia

Image: 
Matthew Walsh, UTA associate professor of biology.

Researchers from The University of Texas at Arlington resurrected the preserved eggs of a shrimp-like crustacean to examine long-standing questions about adaptive evolution, reporting the results in the journal Proceedings of the National Academy of Science.

The study explores the evolutionary impacts of species invasions by studying Daphnia, a shrimp-like crustacean also known as the water flea. Matthew Walsh, associate professor of biology; Alex Landy, UTA postdoctoral researcher; and their colleagues collected sediment cores containing the preserved eggs of Daphnia from lakes in Wisconsin following the invasion of a novel predator. The researchers then "resurrected" the eggs in hopes of seeing novel evolutionary processes in real time.

"Each layer of the sediment core represents a distinct time period and contains a generation of water flea eggs that sank to the lake floor," Walsh said. "By hatching the eggs, we are able to measure the viability and traits of water fleas from before, during and after the invasion of the novel predator."

According to the study, variations in how the ancestors responded to the novel predator were central to water flea adaptation. Yet few studies have been able to assess the characteristics of ancestral populations prior to a change in the environment, Walsh said.

"The key advance illustrated by our work is that the resurrected ancestral lineages of Daphnia revealed extensive genetic variation in their responses to exposure to a novel predator," Walsh said. "Such variation in plasticity provided a template for evolution to proceed following the establishment of the predator."

Walsh added that his team's work is important because it allows researchers to observe evolutionary processes in real time to better understand how organisms adapt to changes in environmental conditions, such as rising temperatures, habitat loss or species invasions.

"Our results highlight the importance of quantifying genetic variation in plasticity when evaluating the drivers of evolutionary change in the wild," Walsh said. "Furthermore, our work calls for more studies that quantify genetic variation in ancestral populations to better understand how and why evolution occurs in a natural setting."

Credit: 
University of Texas at Arlington

Baricitinib plus Remdesivir shows promise for treating COVID-19

image: This colorized transmission electron micrograph shows a SARS-CoV-2 virus particle, isolated from a patient.

Image: 
NIAID

WHAT:

The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The clinical trial is the second iteration of the NIH Adaptive COVID-19 Treatment Trial (ACTT-2), a study protocol to evaluate therapeutics for people hospitalized with COVID-19. Remdesivir is a broad-spectrum antiviral treatment developed by Gilead Sciences, Inc. Baricitinib was discovered by Incyte and licensed to Eli Lilly and Company, and marketed under the brand name Olumiant. It is approved in more than 70 countries as a treatment for adults with moderately-to-severely active rheumatoid arthritis. Researchers hypothesized that because many severe symptoms of COVID-19 are caused by a poorly regulated inflammatory response, a therapeutic designed to target inflammation could be helpful for patients. The primary results of this study were first announced in September.

The ACTT-2 trial opened on May 8, 2020 and enrolled a total of 1,033 volunteer participants at sites in eight countries. Once enrolled, participants were randomized to receive a treatment regimen of either oral baricitinib tablets and intravenous (IV) remdesivir or oral placebo tablets and IV remdesivir.

In the study, the combination of baricitinib and remdesivir reduced median time to recovery in hospitalized COVID-19 patients from eight days to seven days. Patients who required high-flow oxygen or non-invasive ventilation during their hospitalization appeared to have had the largest benefit: their median time to recovery was shortened from 18 days to ten days. In addition, participants' conditions at day 15 of the study (as measured by an eight-category ordinal scale which ranked the severity of their condition) was significantly improved when they received the two therapeutics combined. Recipients of the two treatments also had slightly fewer serious adverse effects.

The researchers caution that comparing this COVID-19 treatment regimen versus those with other therapeutics, such as dexamethasone, is difficult without additional comparison studies. These results do appear to show that baricitinib plus remdesivir can benefit some COVID-19 patients and the combination deserves further clinical study, according to the researchers.

Credit: 
NIH/National Institute of Allergy and Infectious Diseases

Tanzania farmers distrust fertilizer quality, are less willing to pay for it

image: University of Illinois researchers examined fertilizer use in Tanzania.

Image: 
Anna Fairbairn.

URBANA, Ill. - Smallholder farmers in Sub-Saharan Africa use fertilizer well below recommended rates, contributing to consistently low agricultural productivity. Farmers in Tanzania and Kenya, for example, apply just 13 kilograms of fertilizer per hectare, compared with 165 to 175 kilograms in India and Brazil. Low use directly affects cereal yields, which average 1.2 to 1.7 metric tons per hectare, compared to 4 to 4.5 metric tons in South America and Asia.

A new study from the University of Illinois finds farmers have misconceptions about fertilizer quality and suggests those misconceptions are a major reason for low application rates.

"Farmers were not using much fertilizer; that's well established in the region of Tanzania where we were working. In discussions with farmers we heard again and again the explanation was they thought the fertilizer was fake or bad, and they didn't want to buy it," says Hope Michelson, associate professor in the Department of Agricultural and Consumer Economics (ACE) at U of I.

"I'd heard this in other, similar locations where I'd worked with farmers," Michelson says. "We decided to focus on this question of quality: Is the fertilizer bad?"

Michelson and her colleagues conducted a case study in Tanzania to gain more insight into fertilizer quality and farmers' beliefs and willingness to buy it.

Anna Fairbairn, then-graduate student in ACE and co-author on the study, spent a year collecting data throughout Tanzania's Morogoro Region.

Fairbairn first conducted a census to identify all shops in the region selling fertilizer. She drove with her team along primary and secondary roads for weeks, stopping at any shop that looked like it might sell fertilizer. They interviewed all dealers about their practices and prices. Then, "mystery shoppers" posing as farmers purchased more than 600 fertilizer samples from 225 dealers, recording prices and other details about the transactions. The samples went to laboratories in Kenya and the U.S. for analysis.

The researchers included three types of fertilizer that are important for ag production in Tanzania - urea, calcium ammonium nitrate (CAN), and diammonium phosphate (DAP). The lab results showed just a small percentage of samples were marginally out of compliance with industry standards. They did not indicate widespread evidence of the fraud and quality problems that farmers worried about. These results are consistent with findings from numerous academic studies and from international organizations like the International Fertilizer Development Center conducted in recent years.

"It makes sense that the quality is good. Urea fertilizer is difficult to adulterate, and it is one of the cheapest fertilizers. You would have to dilute it with something even cheaper, and there are not very many options. So it is not likely to happen," Michelson notes.

After the quality analysis, Fairbairn and her assistants interviewed 165 farmers in 12 villages across the region. They set up a "store," where they showed farmers samples of urea - the most prevalent fertilizer for small farmers - and asked how much they would be willing to pay for them.

"We found evidence that farmers worry about the quality of the fertilizer in the marketplace, and that impacts their willingness to pay for it. This can affect the amount of fertilizer they're buying, and whether or not they purchase fertilizer at all," Michelson states.

After the farmers' initial responses, the researcher would tell them that the fertilizer had been lab tested and shown to have adequate nutrition content. This information increased the farmers' willingness to pay by about 50%.

Michelson says there may be several explanations for the farmers' distrust in fertilizer quality.

"These farmers are operating in contexts with weak regulatory systems and may be broadly suspicious. It is interesting and significant to find evidence that farmers' beliefs are not converging to the truth - of good quality fertilizer in the marketplace - over time," she states.

Michelson says farmer distrust could be exacerbated by the difficulty in observing the effect of fertilizer on crop yields.

"You could be applying at the wrong time, or not applying enough. Weather is also a factor driving crop yields. You can't always tell if the fertilizer is doing anything because of the rainfall variability factor. Farmers could blame these things on the fertilizer not being good quality," she says.

An important factor that may influence the beliefs the researchers identified is the appearance of the fertilizer. "We find evidence there is an enormous problem with fertilizer in the marketplace that looks bad. It may be dirty or have clumps, sticks, and small amounts of impurities in it," Michelson notes. "More than 30% of the samples we purchased had this sort of problem."

Wholesalers import urea through the port of Dar es Salaam, where it gets bagged and transported into the country. Inadequate storage facilities and transportation resources can result in a compromised appearance that has no bearing on quality and effectiveness.

The research confirmed that farmers were willing to pay less for fertilizer with this poor physical appearance.

For smallholder farmers, purchasing fertilizer is a substantial expense, amounting to about 10% of annual per capita income in the household. It's a non-trivial investment that comes with a measure of risk. And they are not willing to make that investment if they do not believe it will be worth the cost, Michelson notes.

The researchers conclude misconceptions about fertilizer quality could severely hamper crop productivity in developing countries, and additional research can help further explore those correlations and the persistence of these misconceptions in the marketplace.

Credit: 
University of Illinois College of Agricultural, Consumer and Environmental Sciences

Researchers rank various mask protection, modifications against COVID-19

image: Medical procedure mask and modifications designed to enhance mask fit or comfort for the wearer. A mask w/ear loops (A) modified by tying the ear loops and tucking in the side pleats (B), attaching ear loops to a 3D-printed "ear guard" (C), fastening ear loops with a 23mm claw-type hair clip placed behind the wearer's head (D), placing ring of three, ganged, rubber bands over the mask and around the wearer's ears (E), and sliding a 10-inch segment of nylon hosiery over the fitted mask (F).

Image: 
UNC School of Medicine

CHAPEL HILL, NC - It's been shown that when two people wearing masks interact, the chance of COVID-19 transmission is drastically reduced. This is why public health officials have pleaded for all people to wear masks: they not only protect the wearer from expelling particles that might carry SARS-CoV-2, the virus that causes coronavirus 2019 (COVID-19), but masks also protect the wearer from inhaling particles that carry the virus. Some people, though, still refuse to wear a mask. So UNC School of Medicine scientists, in collaboration with the Environmental Protection Agency, researched the protectiveness of various kinds of consumer-grade and modified masks, assuming the mask wearer was exposed to the virus, like when we interact with an unmasked infected person.

Published in the journal JAMA Internal Medicine, the research shows that some masks were as much as 79 percent effective at blocking particles that could carry the virus. These were masks made of two layers of woven nylon and fit snug against the wearer's face. Unmodified medical procedure masks with ear loops - also known as surgical masks - offered 38.5 percent filtration efficacy, but when the ear loops were tied in a specific way to tighten the fit, the efficacy improved to 60.3 percent. And when a layer of nylon was added, these masks offered 80 percent effectiveness.

"While modifications to surgical masks can enhance the filtering capabilities and reduce inhalation of airborne particles by improving the fit of the mask, we demonstrated that the fitted filtration efficiencies of many consumer-grade masks were nearly equivalent to or better than surgical masks," said co-first author Phillip Clapp, PhD, an inhalation toxicologist and assistant professor of pediatrics at the UNC School of Medicine.

Co-first author Emily Sickbert-Bennett, PhD, director of infection prevention at the UNC Medical Center, added, "Limiting the amount of virus is important because the more viral particles we're exposed to, the more likely it is we will get sick and potentially severely ill."

As the adoption of face coverings during the COVID-19 pandemic became commonplace, there was a rapid expansion in the public use of commercial, home-made, and improvised masks which vary considerably in design, material, and construction. There have been a number of innovative "hacks," devices, and mask enhancements that claim to improve the performance characteristics of conventional masks - typically surgical or procedure masks. Despite their widespread dissemination and use during the pandemic, there have been few evaluations of the efficiency of these face coverings or mask enhancements at filtering airborne particles.

In this study, the researchers used a recently described methodological approach based on the OSHA Fit Test to determine the fitted filtration efficiency (FFE) of a variety of consumer-grade and improvised facemasks, as well as several popular modifications of medical procedure masks. Seven consumer-grade masks and five medical procedure mask modifications were fitted on an adult male, and FFE measurements were collected during a series of repeated movements of the torso, head, and facial muscles as outlined by the OSHA Quantitative Fit Testing Protocol.

Here are the different mask types with filtration efficacy. Bolded below is the top-of-the-line N-95 mask, which proved to be 98 percent effective.

Consumer-grade facemasks:

2-layer woven nylon mask, ear loops, w/o aluminum nose bridge: 44.7%
2-layer woven nylon mask, ear loops, w/ aluminum nose bridge: 56.7%
2-layer woven nylon mask, ear loops, w/ nose bridge, 1 non-woven insert: 74.4%
2-later woven nylon mask, ear loops, w/ nose bridge, washed, no insert: 79%
Cotton bandana - folded Surgeon General style: 50%
Cotton bandana - folded "Bandit" style: 49 %
Single-layer woven polyester gaiter/neck cover (balaclava bandana): 37.8%
Single-layer woven polyester/nylon mask with ties: 39.7%
Non-woven polypropylene mask with fixed ear loops: 28.6%
Three-layer woven cotton mask with ear loops: 26.5%

Medical facemasks and modifications:

3M 9210 NIOSH-approved N95 Respirator: 98%
Surgical mask with ties: 71.4%
Procedure mask with ear loops: 38.5%
Procedure mask with ear loops + "loops tied and corners tucked in": 60.3%
Procedure mask with ear loops + "Ear Guard": 61.7%
Procedure mask with ear loops + "23mm claw hair clip": 64.8%
Procedure mask with ear loops + "Fix-the Mask (3 rubber bands)": 78.2%
Procedure mask with ear loops + "nylon hosiery sleeve": 80.2%

Credit: 
University of North Carolina Health Care

A saliva-based smartphone platform could rapidly expand COVID-19 testing

Offering an ultrasensitive yet accessible approach to COVID-19 testing, a portable saliva-based smartphone platform provides results within 15 minutes without the resource-intensive laboratory tests the current gold standard requires, according to a new study. The approach was tested in 12 people infected with COVID-19 and 6 healthy controls. Bo Ning and colleagues demonstrate that this technique, which pairs a fluorescence microscope readout device with a smartphone to determine viral load from a CRISPR/Cas12a assay, works as effectively as the well-established quantitative reverse-transcriptase polymerase chain reaction (RT-qPCR) method. "We believe this smartphone platform, a similar future application, offers the potential to rapidly expand COVID-19 screening capacity, and potentially simplify the verification of contact tracing, to improve local containment and inform regional disease control efforts," the authors write. Most COVID-19 tests currently require swabbing the upper part of the throat behind the nose - an uncomfortable process that requires medical professionals in full protective gear to collect samples in airborne infection isolation rooms before running RT-qPCR tests. However, recent studies have found that SARS-CoV-2 may be equally present in the nasopharynx and the saliva during early infection, suggesting saliva-based COVID-19 tests could enable comparably reliable but simpler, safer testing. To develop a widely accessible platform for saliva-based testing, Ning and colleagues built a prototype assay chip that uses the CRISPR/Cas12a enzyme to enhance an amplified viral RNA target's signal within a saliva sample. They integrated the chip into a smartphone-based fluorescence microscope readout device, which captures and analyzes images to determine whether the virus is present above a threshold concentration. The researchers used this design to analyze saliva from 12 patients with COVID-19 and 6 healthy controls, finding that the approach successfully distinguished between patients with and without the virus. Additionally, the researchers compared nasal and saliva swabs from non-human primates before and after infection. They found higher SARS-CoV-2 RNA levels in the saliva swabs, further suggesting that saliva may provide a robust means of diagnosis after infection. Ning et al. anticipate that a future version of the chip used in this technique could contain pre-loaded reagents and sample controls, and a custom smartphone app could enable secure, wireless test data reporting to support telehealth efforts.

Credit: 
American Association for the Advancement of Science (AAAS)